2 active shortage notices · 1 country. Tbo-Filgrastim has 2 active shortage notices across 1 country (United States). Information last verified by Mederti on 11 Nov 2026, based on notices published by FDA.
| Country | Severity | Notices | Since | Est. resolution | Source |
|---|---|---|---|---|---|
| United States | medium | 2 | 13 Jun 2025 | — | FDA |
Yes. As of the latest regulator updates, Tbo-Filgrastim has 2 active shortage notices across 1 country (United States). Status is refreshed daily from official regulatory sources.
Regulators attribute the current Tbo-Filgrastim shortages to product discontinuation. The exact cause varies by country and product — each notice on this page links to the official source.
Every shortage notice on this page is scraped daily from an official national medicines regulator (such as the FDA, TGA, MHRA or EMA) and linked back to its source. Mederti aggregates 40+ official regulators across 35+ countries and never publishes unsourced shortage claims.
Free for individual pharmacists and clinicians — watchlists, email alerts, alternatives and country-by-country product detail.
Create a free accountMederti is an independent information service that aggregates notices published by official national medicines regulators, checked daily. It is not a regulator and is not affiliated with or endorsed by any regulator. A regulator's shortage status does not confirm or rule out commercial stock at any pharmacy or wholesaler. This page is not clinical advice; check the official notice and consult a pharmacist or prescriber before changing treatment.